Table 5.
Comparison of reported cost estimates in relation to cervical cancer for China
| Study | Year of estimation (article language) | Study population | Rural or urban setting | Overall study design | Cost data collection | Perspective | Cost category covered | Reported cost of select or available items (US$) |
|---|---|---|---|---|---|---|---|---|
| The current study |
2008–2009 (English) |
Shanxi, Prov. |
Rural |
Purely costing study |
Micro-costing approach (county and prefecture level) |
Societal (direct medical and non-medical costs) |
Screening, diagnosis and treatment |
Indicated in Tables 1, 2, 3, and 4 of the manuscript |
| Shi et al 2011, Canfell et al 2011 [4,5] |
2008 (English) |
Shanxi, Prov. |
Rural |
Cost-effectiveness analysis |
Micro-costing for screening, diagnosis and part of treatment (LEEP and simple hysterectomy); Checking audits of hospital charges to estimate cancer treatment costs |
Societal (direct medical and non-medical costs) |
Screening, diagnosis and treatment |
VIA screening: $3.55 (mobile), $4.30 (program-based); VILI screening: $0.40; careHPV: $9.20 (self-sampling), $10.34 (provider-sampling); LEEP: $55.95; Cancer treatment: $628 (FIGO I); $1953 (FIGO II); $1810 (FIGO III); $663 (FIGO IV) |
| Levin et al 2009 [3] |
2005 (English) |
Shanxi, Prov. (Rural) |
Rural |
Cost-effectiveness analysis |
Micro-costing (county and national level) |
Societal (direct medical and non-medical costs) |
Screening, diagnosis and treatment |
Direct medical costs at a county level: Colposcopy: ~$8.21; Biopsy: ~$15.46; LEEP: ~$87.58; CKC: ~$87.13; Simple hysterectomy: ~$354; Local cancer: ~$387; Regional/distant cancer: ~$1,739 |
| Goldie et al 2005 [8] |
2005 (English) |
25 Asia Pacific regions, including China |
Not indicated |
Broad cost- effectiveness analysis |
Leveraged available data in select other countries and extrapolate to China based on several indicators, including gross domestic product per capita |
Societal |
Screening, diagnosis and treatment |
Average direct medical cost of cervical cancer treatment: ~I$1,500 for cancer stage I, ~I$1,700 for cancer stage II–IV |
| Deng et al 2010 [14] |
2006 (Chinese) |
A county-level site (Liuyang) in Hunan Prov. |
Rural |
Cost-benefit analysis |
Standard hospital charges (released by the local Office of Health of Hunan Prov.) for screening and diagnosis; expert opinion for treatment |
Medical cost only |
Screening, diagnosis and treatment |
Pap smear screening: ~$4; Colposcopy: ~$13; Biopsy (one punch): ~$18; CKC: ~$585; Radical hysterectomy: $1,756; Mainly chemo/ radiotherapy: ~$3,658 |
| Wang et al 2009 [16] |
1996–2006 (Chinese) |
Lanzhou City, Gansu Prov. |
Urban |
Time-trend analysis of in-patient hospitalization fee (cervical cancer and breast cancer) |
Hospital bill audits review (N = 1,564) |
In-patient fee only |
Cancer treatment only |
Average treatment expense per patient with cervical cancer: ~$1,464 (2006) and ~ $1,185 (1996–2006) |
| Guan et al 2004 [15] |
1997–2001 (Chinese) |
Wuhan City, Hubei Prov. |
Urban |
Time-trend analysis of in-patient hospitalization fee (cervical cancer only) |
Hospital bill audits review (N = 106) |
In-patient fee only |
Cancer treatment only |
Average treatment expense per patient with cervical cancer: ~$1,390 (1997–2001) |
| Tan et al 2003 [13] | 1996–2001 (Chinese) | Beijing City | Urban | Analysis of in-patient hospitalization fee and clinical outcomes (Hysterectomy only) | Hospital bill audits review (N = 4,180) | In-patient fee only | Treatment only | Average treatment expense of various hysterectomy types: ~$736 - ~ $1,094 |